327 related articles for article (PubMed ID: 17636771)
1. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Doyle LW; Crowther CA; Middleton P; Marret S
Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
[TBL] [Abstract][Full Text] [Related]
3. Magnesium sulphate for women at term for neuroprotection of the fetus.
Nguyen TM; Crowther CA; Wilkinson D; Bain E
Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Shepherd ES; Goldsmith S; Doyle LW; Middleton P; Marret S; Rouse DJ; Pryde P; Wolf HT; Crowther CA
Cochrane Database Syst Rev; 2024 May; 5(5):CD004661. PubMed ID: 38726883
[TBL] [Abstract][Full Text] [Related]
5. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
6. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
[TBL] [Abstract][Full Text] [Related]
7. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.
Shepherd E; Salam RA; Middleton P; Makrides M; McIntyre S; Badawi N; Crowther CA
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012077. PubMed ID: 28786098
[TBL] [Abstract][Full Text] [Related]
8. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
Doyle LW; Crowther CA; Middleton P; Marret S
Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
[TBL] [Abstract][Full Text] [Related]
9. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
Crowther CA; Brown J; McKinlay CJ; Middleton P
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD001060. PubMed ID: 25126773
[TBL] [Abstract][Full Text] [Related]
11. Antenatal magnesium sulphate neuroprotection in the preterm infant.
Marret S; Doyle LW; Crowther CA; Middleton P
Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
[TBL] [Abstract][Full Text] [Related]
12. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
[TBL] [Abstract][Full Text] [Related]
13. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
14. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
15. Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.
Bain E; Middleton P; Crowther CA
Cochrane Database Syst Rev; 2012 Feb; (2):CD009302. PubMed ID: 22336863
[TBL] [Abstract][Full Text] [Related]
16. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
Crowther CA; Hiller JE; Doyle LW
Cochrane Database Syst Rev; 2002; (4):CD001060. PubMed ID: 12519550
[TBL] [Abstract][Full Text] [Related]
17. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
[TBL] [Abstract][Full Text] [Related]
18. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
19. Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32 weeks of gestation in Japan.
Ohhashi M; Yoshitomi T; Sumiyoshi K; Kawagoe Y; Satoh S; Sameshima H; Ikenoue T
Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():140-5. PubMed ID: 27131232
[TBL] [Abstract][Full Text] [Related]
20. Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).
AMICABLE Group
Syst Rev; 2012 Mar; 1():21. PubMed ID: 22587882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
